Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares reached a new 52-week low on Monday . The stock traded as low as $4.57 and last traded at $4.70, with a volume of 142891 shares. The stock had previously closed at $4.61.
Evotec Price Performance
The firm has a market cap of $1.55 billion, a P/E ratio of 11.24 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The business’s 50 day moving average is $4.44 and its two-hundred day moving average is $4.28.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- What Are Dividend Achievers? An Introduction
- How to Master Trading Discipline: Overcome Emotional Challenges
- Investing In Automotive Stocks
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- What is Short Interest? How to Use It
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
